Press Resease

Sepsis Diagnostics Market by Product (Instruments, Blood Culture Media, and Assay Kits and Reagents), by Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Microfluidics, and Biomarkers), by Pathogen Type (Bacterial Sepsis [Gram-Positive Bacteria and Gram-Negative Bacteria], Fungal Sepsis, and Others), by Method (Conventional Diagnostics and Automated Diagnostics), and by Test Type (Laboratory Tests and Point-Of-Care Tests): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2025

Published Date: 01-Feb-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-3787 Status : Published

Global sepsis diagnostics market expected to generate around USD 792 million by 2025, at a CAGR of around 8.70% between 2019 and 2025. The increasing demand for antibiotic-resistant bacterial strains and growing incidences of hospital-acquired infections are likely to boost the sepsis diagnostics market globally in the future.

Description

The report covers a forecast and an analysis of the sepsis diagnostics market on a global and regional level. The study provides historic data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the sepsis diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the sepsis diagnostics market on a global level.

In order to give the users of this report a comprehensive view of the sepsis diagnostics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Sepsis Diagnostics Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the sepsis diagnostics market by segmenting the market based on product, technology, pathogen type, method, test type, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries.

Some leading players of the global sepsis diagnostics market are Danaher, Immunexpress, Biomerieux, Thermo Fisher Scientific, Becton, Dickinson, and Company, Response Biomedical, Bruker, Luminex, Roche Diagnostics, and T2 Biosystems.

This report segments the global sepsis diagnostics market into:

Global Sepsis Diagnostics Market: Product Analysis

  • Instruments
  • Blood Culture Media
  • Assay Kits and Reagents

Global Sepsis Diagnostics Market: Technology Analysis

  • Microbiology
  • Molecular Diagnostics 
  • Immunoassays
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

Global Sepsis Diagnostics Market: Pathogen Type Analysis

  • Bacterial Sepsis 
    • Gram-Positive Bacteria
    • Gram-Negative Bacteria
  • Fungal Sepsis
  • Others

Global Sepsis Diagnostics Market: Method Analysis

  • Conventional Diagnostics
  • Automated Diagnostics

Global Sepsis Diagnostics Market: Test Type Analysis

  • Laboratory Tests 
  • Point-Of-Care Tests

Global Sepsis Diagnostics Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global sepsis diagnostics market,2016-2025 (USD Million)
    • 2.2. Global sepsis diagnostics market: snapshot
  •  
  • Chapter 3. Sepsis Diagnostics Market- Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global sepsis diagnostics market drivers: impact analysis
      • 3.2.2. The growing incidence of hospital-acquired infections
      • 3.2.3. The increasing burden of pneumonia
      • 3.2.4. High incidence of sepsis in the adult population
      • 3.2.5. An increasing number of surgical procedures
      • 3.2.6. Rising initiatives to increase awareness and drive the adoption of sepsis diagnostic tests
    • 3.3. Market Restraints
      • 3.3.1. Global sepsis diagnostics market restraints: impact analysis
      • 3.3.2. Lack of established reimbursement policies for sepsis
      • 3.3.3. The high cost of automated diagnostic devices
    • 3.4. Opportunities
      • 3.4.1. Development of rapid diagnostic/POC techniques for early sepsis diagnosis
      • 3.4.2. Evolution of novel biomarkers for sepsis diagnosis
    • 3.5. Porter's Five Forces Analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product
      • 3.6.2. Market attractiveness analysis, by technology
      • 3.6.3. Market attractiveness analysis, by pathogen type
      • 3.6.4. Market attractiveness analysis, by method
      • 3.6.5. Market attractiveness analysis, by test type
      • 3.6.6. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Sepsis Diagnostics Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global sepsis diagnostics market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Sepsis Diagnostics Market - Product Analysis
    • 5.1. Global sepsis diagnostics market: product overview
      • 5.1.1. Global sepsis diagnostics market revenue share, by product, 2016 and 2025
    • 5.2. Instruments
      • 5.2.1. Global sepsis diagnostics market for instruments, 2016-2025 (USD Million)
    • 5.3. Blood Culture Media
      • 5.3.1. Global sepsis diagnostics market for blood culture media, 2016-2025 (USD Million)
    • 5.4. Assay Kits and Reagents
      • 5.4.1. Global sepsis diagnostics market for assay kits and reagents,2016-2025 (USD Million)
  •  
  • Chapter 6. Global Sepsis Diagnostics Market - Technology Analysis
    • 6.1. Global sepsis diagnostics market: technology overview
      • 6.1.1. Global sepsis diagnostics market revenue share, by technology, 2016 and 2025
    • 6.2. Microbiology
      • 6.2.1. Global sepsis diagnostics market for microbiology, 2016-2025 (USD Million)
    • 6.3. Molecular Diagnostics
      • 6.3.1. Global sepsis diagnostics market for molecular diagnostics, 2016-2025 (USD Million)
    • 6.4. Immunoassays
      • 6.4.1. Global sepsis diagnostics market for immunoassays, 2016-2025 (USD Million)
    • 6.5. Flow Cytometry
      • 6.5.1. Global sepsis diagnostics market for flow cytometry, 2016-2025 (USD Million)
    • 6.6. Microfluidics
      • 6.6.1. Global sepsis diagnostics market for microfluidics, 2016-2025 (USD Million)
    • 6.7. Biomarkers
      • 6.7.1. Global sepsis diagnostics market for Biomarkers, 2016-2025 (USD Million)
  •  
  • Chapter 7. Global Sepsis Diagnostics Market - Pathogen Type Analysis
    • 7.1. Global sepsis diagnostics market: pathogen type overview
      • 7.1.1. Global sepsis diagnostics market revenue share, by pathogen type, 2016 and 2025
    • 7.2. Bacterial Sepsis
      • 7.2.1. Global sepsis diagnostics market for bacterial sepsis, 2016-2025 (USD Million)
        • 7.2.1.1. Gram-Positive Bacteria
          • 7.2.1.1.1. Global bacterial sepsis market for gram-positive bacteria, 2016-2025 (USD Million)
        • 7.2.1.2. Gram-Negative Bacteria
          • 7.2.1.2.1. Global bacterial sepsis market for gram-negative bacteria, 2016-2025 (USD Million)
    • 7.3. Fungal Sepsis
      • 7.3.1. Global sepsis diagnostics market for fungal sepsis, 2016-2025 (USD Million)
    • 7.4. Others
      • 7.4.1. Global sepsis diagnostics market for others, 2016-2025 (USD Million)
  •  
  • Chapter 8. Global Sepsis Diagnostics Market - Method Analysis
    • 8.1. Global sepsis diagnostics market: method overview
      • 8.1.1. Global sepsis diagnostics market revenue share, by method, 2016 and 2025
    • 8.2. Conventional Diagnostics
      • 8.2.1. Global sepsis diagnostics market for conventional diagnostics, 2016-2025 (USD Million)
    • 8.3. Automated Diagnostics
      • 8.3.1. Global sepsis diagnostics market for automated diagnostics, 2016-2025 (USD Million)
  •  
  • Chapter 9. Global Sepsis Diagnostics Market - Test Type Analysis
    • 9.1. Global sepsis diagnostics market: test type overview
      • 9.1.1. Global sepsis diagnostics market revenue share, by test type, 2016 and 2025
    • 9.2. Laboratory Tests
      • 9.2.1. Global sepsis diagnostics market for laboratory tests, 2016-2025 (USD Million)
    • 9.3. Point-Of-Care Tests
      • 9.3.1. Global sepsis diagnostics market for point-of-care tests, 2016-2025 (USD Million)
  •  
  • Chapter 10. Global Sepsis Diagnostics Market- Regional Analysis
    • 10.1. Global sepsis diagnostics market: regional overview
      • 10.1.1. Global sepsis diagnostics market revenue share, by region, 2016 and 2025
    • 10.2. North America
      • 10.2.1. North America sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
      • 10.2.2. North America sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
      • 10.2.3. North America sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
      • 10.2.4. North America sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
      • 10.2.5. North America sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.2.6. The U.S.
        • 10.2.6.1. The U.S. sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.2.6.2. The U.S. sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.2.6.3. The U.S. sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.2.6.4. The U.S. sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.2.6.5. The U.S. sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.2.7. Canada
        • 10.2.7.1. Canada sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.2.7.2. Canada sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.2.7.3. Canada sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.2.7.4. Canada sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.2.7.5. Canada sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
    • 10.3. Europe
      • 10.3.1. Europe sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
      • 10.3.2. Europe sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
      • 10.3.3. Europe sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
      • 10.3.4. Europe sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
      • 10.3.5. Europe sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.3.6. UK
        • 10.3.6.1. UK sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.3.6.2. UK sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.3.6.3. UK sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.3.6.4. UK sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.3.6.5. UK sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.3.7. Germany
        • 10.3.7.1. Germany sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.3.7.2. Germany sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.3.7.3. Germany sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.3.7.4. Germany sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.3.7.5. Germany sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.3.8. France
        • 10.3.8.1. France sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.3.8.2. France sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.3.8.3. France sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.3.8.4. France sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.3.8.5. France sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.3.9. Rest of Europe
        • 10.3.9.1. Rest of Europe sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.3.9.2. Rest of Europe sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.3.9.3. Rest of Europe sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.3.9.4. Rest of Europe sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.3.9.5. Rest of Europe sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
      • 10.4.2. Asia Pacific sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
      • 10.4.3. Asia Pacific sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
      • 10.4.4. Asia Pacific sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
      • 10.4.5. Asia Pacific sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.4.6. China
        • 10.4.6.1. China sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.4.6.2. China sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.4.6.3. China sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.4.6.4. China sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.4.6.5. China sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.4.7. Japan
        • 10.4.7.1. Japan sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.4.7.2. Japan sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.4.7.3. Japan sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.4.7.4. Japan sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.4.7.5. Japan sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.4.8. India
        • 10.4.8.1. India sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.4.8.2. India sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.4.8.3. India sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.4.8.4. India sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.4.8.5. India sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.4.9. Rest of Asia Pacific
        • 10.4.9.1. Rest of Asia Pacific sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.4.9.2. Rest of Asia Pacific sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.4.9.3. Rest of Asia Pacific sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.4.9.4. Rest of Asia Pacific sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.4.9.5. Rest of Asia Pacific sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
    • 10.5. Latin America
      • 10.5.1. Latin America sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
      • 10.5.2. Latin America sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
      • 10.5.3. Latin America sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
      • 10.5.4. Latin America sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
      • 10.5.5. Latin America sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.5.6. Brazil
        • 10.5.6.1. Brazil sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.5.6.2. Brazil sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.5.6.3. Brazil sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.5.6.4. Brazil sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.5.6.5. Brazil sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
      • 10.5.7. Rest of Latin America
        • 10.5.7.1. Rest of Latin America sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
        • 10.5.7.2. Rest of Latin America sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
        • 10.5.7.3. Rest of Latin America sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
        • 10.5.7.4. Rest of Latin America sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
        • 10.5.7.5. Rest of Latin America sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
    • 10.6. The Middle East and Africa
      • 10.6.1. The Middle East and Africa sepsis diagnostics market revenue, by product, 2016-2025 (USD Million)
      • 10.6.2. The Middle East and Africa sepsis diagnostics market revenue, by technology, 2016-2025 (USD Million)
      • 10.6.3. The Middle East and Africa sepsis diagnostics market revenue, by pathogen type, 2016-2025 (USD Million)
      • 10.6.4. The Middle East and Africa sepsis diagnostics market revenue, by method, 2016-2025 (USD Million)
      • 10.6.5. The Middle East and Africa sepsis diagnostics market revenue, by test type, 2016-2025 (USD Million)
  •  
  • Chapter 11. Company Profile
    • 11.1. Danaher
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Product portfolio
      • 11.1.4. Business strategy
      • 11.1.5. Recent developments
    • 11.2. Immunexpress
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Product portfolio
      • 11.2.4. Business strategy
      • 11.2.5. Recent developments
    • 11.3. Biomerieux
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Product portfolio
      • 11.3.4. Business strategy
      • 11.3.5. Recent developments
    • 11.4. Thermo Fisher Scientific
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Product portfolio
      • 11.4.4. Business strategy
      • 11.4.5. Recent developments
    • 11.5. Becton, Dickinson, and Company
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Product portfolio
      • 11.5.4. Business strategy
      • 11.5.5. Recent developments
    • 11.6. Response Biomedical
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Product portfolio
      • 11.6.4. Business strategy
      • 11.6.5. Recent developments
    • 11.7. Bruker
      • 11.7.1. Overview
      • 11.7.2. Financials
      • 11.7.3. Product portfolio
      • 11.7.4. Business strategy
      • 11.7.5. Recent developments
    • 11.8. Luminex
      • 11.8.1. Overview
      • 11.8.2. Financials
      • 11.8.3. Product portfolio
      • 11.8.4. Business strategy
      • 11.8.5. Recent developments
    • 11.9. Roche Diagnostics
      • 11.9.1. Overview
      • 11.9.2. Financials
      • 11.9.3. Product portfolio
      • 11.9.4. Business strategy
      • 11.9.5. Recent developments
    • 11.10. T2 Biosystems
      • 11.10.1. Overview
      • 11.10.2. Financials
      • 11.10.3. Product portfolio
      • 11.10.4. Business strategy
      • 11.10.5. Recent developments

Methodology

Free Analysis

Sepsis is a life-threatening condition caused by bacterial infection. This disease injures the tissues and organs. As per physicians, it is a three-staged syndrome disease—sepsis, severe sepsis, and septic shock. Severe sepsis is associated with acute alteration in the mental status and organ dysfunction, whereas septic shock is defined as severe sepsis with signs of rapidly falling blood pressure, organ dysfunction, and abnormalities in cellular metabolism, all of which are considered as medical emergencies.

The increasing demand for antibiotic-resistant bacterial strains and growing incidences of hospital-acquired infections are likely to boost the sepsis diagnostics market globally in the future. The rising incidences of HAI’s (hospital-acquired infections) are anticipated to be the major growth driver of the global sepsis diagnostics market in the upcoming years. HAIs trigger sepsis mainly in individuals who have weak immunity or are at an increased risk of being diagnosed with chronic diseases. As per the Center for Disease Control and Prevention, about 1 among every 25 hospitalized patients has at least one healthcare-associated infection on a given day in the hospital in the U.S. Hence, the growing incidences of HAIs are likely to boost the sepsis diagnostics market in the years ahead. Other factors that are projected to drive this market’s growth in the future include a growing number of pneumonia cases and increased funding for research activities related to sepsis.

Global Sepsis Diagnostics Market

The global sepsis diagnostics market is segmented on the basis of product, technology, pathogen type, method, and test type. By product type, the market is segmented into blood culture media, assay kits and reagents, and instruments. The technology segment includes immunoassays, microbiology, microfluidics, molecular diagnostics, biomarkers, and flow cytometry. By pathogen type, the sepsis diagnostics market includes fungal sepsis, bacterial sepsis, and others. The bacterial sepsis segment is further segmented into gram-negative bacteria and gram-positive bacteria. By the method, the sepsis diagnostics market includes automated diagnostics and conventional diagnostics. By test type, the market is bifurcated into laboratory tests and point-of-care tests.

By region, North America is anticipated to dominate the sepsis diagnostics market globally and hold a major share over the forecast timeline. This can be attributed to the growing adoption of advanced and new diagnostic techniques, rising demand for better healthcare facilities, increasing incidences of chronic diseases, such as diabetes, cancer, etc. leading to increased hospital admissions, and high per capita healthcare expenditure. The Asia Pacific region is projected to register the highest CAGR over the estimated timeframe, owing to the rise in geriatric population, rapidly expanding healthcare infrastructure, and an increase in the prevalence of chronic diseases in China, India, and Australia.

Some leading players of the global sepsis diagnostics market are Danaher, Immunexpress, Biomerieux, Thermo Fisher Scientific, Becton, Dickinson, and Company, Response Biomedical, Bruker, Luminex, Roche Diagnostics, and T2 Biosystems.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com